Plasma proteomic signatures of Parkinson’s disease status, cognitive heterogeneity and longitudinal decline

Cognitive decline is a major source of disability in Parkinson’s disease (PD), yet reliable prognostic biomarkers are still lacking. In this observational study, we analyzed longitudinal plasma proteomics from the Parkinson’s Progression Markers Initiative (PPMI; 199 samples from 68 PD patients and 345 samples from 115 healthy controls; Olink®). We sought to validate our findings cross-sectionally in the Parkinson’s Disease Biomarkers Program (PDBP; 175 PD and 17 HC; SomaScan®). Of the modules with proteins measured on both platforms, the associations for three lysosomal proteins (CTSD, CTSZ, CST3) replicated. We identified 284 proteins distinguishing PD from controls (AUC = 0.88); 63 grouped into five co-expression modules associated with cognition, four of which correlated with regional brain atrophy in at least one analysis. Elevated plasma Cathepsin D (CTSD), Cathepsin Z (CTSZ), and Cystatin C (CST3) levels were linked to both cognitive and motor impairment. In an exploratory analysis, a combined clinical–proteomic model showed preliminary predictive ability to forecast future cognitive decline in a held-out subset of PD participants (R² = 0.365). These findings define a plasma signature of cognitive vulnerability in PD and suggest lysosomal protease dysfunction as a potential contributor.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2026-11-16
DOI
https://doi.org/10.1038/s41531-026-01612-4
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Plasma proteomic signatures of Parkinson’s disease status, cognitive heterogeneity and longitudinal decline

Laurent Cléret de Langavant, Sophie Hüe, Philippe Rémy, Marine Lunven et al.
2 links
npj Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
article

Plasma proteomic signatures of Parkinson’s disease status, cognitive heterogeneity and longitudinal decline

Laurent Cléret de Langavant, Sophie Hüe, Philippe Rémy, Marine Lunven, Hayet Salhi, Robin Louiset, Renaud Massart, Anne-Catherine Bachoud-Lévi
article en

Abstract

Cognitive decline is a major source of disability in Parkinson’s disease (PD), yet reliable prognostic biomarkers are still lacking. In this observational study, we analyzed longitudinal plasma proteomics from the Parkinson’s Progression Markers Initiative (PPMI; 199 samples from 68 PD patients and 345 samples from 115 healthy controls; Olink®). We sought to validate our findings cross-sectionally in the Parkinson’s Disease Biomarkers Program (PDBP; 175 PD and 17 HC; SomaScan®). Of the modules with proteins measured on both platforms, the associations for three lysosomal proteins (CTSD, CTSZ, CST3) replicated. We identified 284 proteins distinguishing PD from controls (AUC = 0.88); 63 grouped into five co-expression modules associated with cognition, four of which correlated with regional brain atrophy in at least one analysis. Elevated plasma Cathepsin D (CTSD), Cathepsin Z (CTSZ), and Cystatin C (CST3) levels were linked to both cognitive and motor impairment. In an exploratory analysis, a combined clinical–proteomic model showed preliminary predictive ability to forecast future cognitive decline in a held-out subset of PD participants (R² = 0.365). These findings define a plasma signature of cognitive vulnerability in PD and suggest lysosomal protease dysfunction as a potential contributor.

npj Parkinson s Disease
Inserm (FR), Université Paris-Est Créteil (FR), Université Paris Sciences et Lettres (FR), École Normale Supérieure - PSL (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpitaux Universitaires Henri-Mondor (FR), Hôpital Albert-Chenevier (FR), Institut Mondor de Recherche Biomédicale (FR)
Association France Parkinson
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon